FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norbert Frey

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Disorders

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Hans-Joerg Hippe; Hugo A Katus; Mark Lüdde; Susanne Lutz; Feraydoon Niroomand; Ana Novakovic; Bernd Nürnberg; Katrin Schnoes; Norbert Frey; Thomas Wieland
Competition for Gβγ dimers mediates a specific cross-talk between stimulatory and inhibitory G protein α subunits of the adenylyl cyclase in cardiomyocytes.
C Kühl; C Langer; Mark Luedde; Norbert Frey
[Diagnosis and treatment of hypertrophic cardiomyopathies].
Sebastian Spaich; Saskia Spaich; Stefan Wiemann; Rainer D Will; Johannes Backs; Ina M Berger; Derk Frank; Steffen Just; Hugo A Katus; Manfred Koegl; Bernhard Korn; Christian Kuhn; Wolfgang Rottbauer; Norbert Frey
F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box protein that regulates sarcomeric protein turnover and is essential for maintenance of contractile function in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norbert Frey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hans-Joerg Hippe; Hugo A Katus; Mark Lüdde; Susanne Lutz; Feraydoon Niroomand; Ana Novakovic; Bernd Nürnberg; Katrin Schnoes; Norbert Frey; Thomas Wieland
Competition for Gβγ dimers mediates a specific cross-talk between stimulatory and inhibitory G protein α subunits of the adenylyl cyclase in cardiomyocytes.
Naunyn-Schmiedeberg's archives of pharmacology 2013;386(6):459-69.
2013: C Kühl; C Langer; Mark Luedde; Norbert Frey
[Diagnosis and treatment of hypertrophic cardiomyopathies].
Deutsche medizinische Wochenschrift (1946) 2013;138(12):583-8.
2012: Sebastian Spaich; Saskia Spaich; Stefan Wiemann; Rainer D Will; Johannes Backs; Ina M Berger; Derk Frank; Steffen Just; Hugo A Katus; Manfred Koegl; Bernhard Korn; Christian Kuhn; Wolfgang Rottbauer; Norbert Frey
F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box protein that regulates sarcomeric protein turnover and is essential for maintenance of contractile function in vivo.
Circulation research 2012;111(12):1504-16.
2012: Mark Rosenberg; Rita Wipplinger; Ekkehard Gruenig; Hugo A Katus; Dirk Lossnitzer; Matthias Lutz; F Joachim Meyer; Norbert Frey
Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.
European journal of clinical investigation 2012;42(9):933-42.
2012: Boris T Ivandic; Hugo A Katus; Sergey E Mastitsky; Frank Schönsiegel; Raffi Bekeredjian; Roland Eils; Norbert Frey; Benedikt Brors
Whole-genome analysis of gene expression associates the ubiquitin-proteasome system with the cardiomyopathy phenotype in disease-sensitized congenic mouse strains.
Cardiovascular research 2012;94(1):87-95.
2012: Mark Rosenberg; Tibor Schuster; Rita Wipplinger; Ekkehard Gruenig; Hugo A Katus; Dirk Lossnitzer; Matthias Lutz; F Joachim Meyer; Norbert Frey
Osteopontin (OPN) improves risk stratification in pulmonary hypertension (PH).
International journal of cardiology 2012;155(3):504-5.
2012: Derk Frank; Inka Boomgaarden; Matthias Eden; Johanne Gantenberg; Kai-Uwe Jarr; Hugo A Katus; Kristin Kramer; Christian Kuhn; Mark Luedde; Heimo Mairbäurl; Rainer Will; Norbert Frey
MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3.
Journal of molecular and cellular cardiology 2012;52(3):711-7.
2012: Norbert Frey; Mark Luedde; Hugo A Katus
Mechanisms of disease: hypertrophic cardiomyopathy.
Nature reviews. Cardiology 2012;9(2):91-100.
2012: Mark Rosenberg; Rainer Will; Volker Eckstein; Hugo A Katus; Jutta Krebs; Constantin Kühl; Matthias Lutz; Norbert Frey
Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT.
Journal of translational medicine 2012;10():115.
2012: Christian Kuhn; Lorenz H Lehmann; Ulrike Oehl; Rainer Will; Johannes Backs; Franziska Dierck; Derk Frank; Hugo A Katus; Jutta Krebs; Norbert Frey
Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
Basic research in cardiology 2012;107(3):262.
2011: Arthur Filusch; Norbert Frey; Hugo A Katus; Thomas Zelniker; Christian Baumgärtner; Sabine Eschricht; Emmanuel Chorianopoulos
Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(10):879-85.
2011: Mark Luedde; Saskia Spaich; Hans-Joerg Hippe; Sebastian Busch; Rainer Will; Issam Abu-Taha; Tilman Klein; Christian Kuhn; Derk Frank; Hugo A Katus; Norbert Frey
Affixin (β-parvin) promotes cardioprotective signaling via STAT3 activation.
Journal of molecular and cellular cardiology 2011;50(5):919-23.
2011: Hendrik Bonnemeier; Gregor Simonis; Goran Olivecrona; Britta Weidtmann; Matthias Götberg; Gunther Weitz; Ivana Gerling; Ruth Strasser; Norbert Frey
Continuous mechanical chest compression during in-hospital cardiopulmonary resuscitation of patients with pulseless electrical activity.
Resuscitation 2011;82(2):155-9.
2010: Hendrik Bonnemeier; Thomas Demming; Britta Weidtmann; Jasmin Ortak; Christof Burgdorf; Michael Reppel; Wanda Mäuser; Mark Rosenberg; Norbert Frey
Differential heart rate dynamics in transient left ventricular apical and midventricular ballooning.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(12):1825-32.
2010: Rainer D Will; Matthias Eden; Steffen Just; Arne Hansen; Alexandra Eder; Derk Frank; Christian Kuhn; Thalia S Seeger; Ulrike Oehl; Stefan Wiemann; Bernhard Korn; Manfred Koegl; Wolfgang Rottbauer; Thomas Eschenhagen; Hugo A Katus; Norbert Frey
Myomasp/LRRC39, a heart- and muscle-specific protein, is a novel component of the sarcomeric M-band and is involved in stretch sensing.
Circulation research 2010;107(10):1253-64.
2010: Derk Frank; Robert Frauen; Christiane Hanselmann; Christian Kuhn; Rainer Will; Johanne Gantenberg; Laszlo Füzesi; Hugo A Katus; Norbert Frey
Lmcd1/Dyxin, a novel Z-disc associated LIM protein, mediates cardiac hypertrophy in vitro and in vivo.
Journal of molecular and cellular cardiology 2010;49(4):673-82.
2010: Emmanuel Chorianopoulos; Kai Jarr; Henning Steen; Evangelos Giannitsis; Norbert Frey; Hugo A Katus
Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome.
Atherosclerosis 2010;211(1):322-6.
2010: Mirko Voelkers; Mareen Salz; Nicole Herzog; Derk Frank; Nima Dolatabadi; Norbert Frey; Natalie Gude; Oliver Friedrich; Walter J Koch; Hugo A Katus; Mark A Sussman; Patrick Most
Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes.
Journal of molecular and cellular cardiology 2010;48(6):1329-34.
2010: Mark Luedde; Philipp Ehlermann; Dieter Weichenhan; Rainer Will; Raphael Zeller; Stefan Rupp; Andreas Müller; Henning Steen; Boris T Ivandic; Herbert E Ulmer; Michael Kern; Hugo A Katus; Norbert Frey
Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation.
Cardiovascular research 2010;86(3):452-60.
2010: Thalia S Seeger; Derk Frank; Claudia Rohr; Rainer Will; Steffen Just; Christine Grund; Robert Lyon; Mark Luedde; Manfred Koegl; Farah Sheikh; Wolfgang Rottbauer; Werner W Franke; Hugo A Katus; Eric N Olson; Norbert Frey
Myozap, a novel intercalated disc protein, activates serum response factor-dependent signaling and is required to maintain cardiac function in vivo.
Circulation research 2010;106(5):880-90.
2010: Emmanuel Chorianopoulos; Thomas Heger; Matthias Lutz; Derk Frank; Florian Bea; Hugo A Katus; Norbert Frey
FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Basic research in cardiology 2010;105(2):301-13.
2009: Emmanuel Chorianopoulos; Mark Rosenberg; Christian Zugck; Johanna Wolf; Hugo A Katus; Norbert Frey
Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure.
European journal of heart failure 2009;11(11):1050-6.
2009: Christian Volz; Christian Erbel; Johannes Berentelg; Hugo A Katus; Norbert Frey
Reversible left ventricular dysfunction resembling Takotsubo syndrome after self-injection of adrenaline.
The Canadian journal of cardiology 2009;25(7):e261-2.
2009: Christian Kuhn; Derk Frank; Rainer Will; Christoph Jaschinski; Robert Frauen; Hugo A Katus; Norbert Frey
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
The Journal of biological chemistry 2009;284(25):17320-7.
2009: Mark Luedde; Ulrich Flögel; Maike Knorr; Christina Grundt; Hans-Joerg Hippe; Benedikt Brors; Derk Frank; Uta Haselmann; Claude Antony; Mirko Voelkers; Juergen Schrader; Patrick Most; Bjoern Lemmer; Hugo A Katus; Norbert Frey
Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.
Journal of molecular medicine (Berlin, Germany) 2009;87(4):411-22.
2009: Frauke Friedrichs; Christian Zugck; Gerd-Jörg Rauch; Boris Ivandic; Dieter Weichenhan; Margit Müller-Bardorff; Benjamin Meder; Nour Eddine El Mokhtari; Vera Regitz-Zagrosek; Roland Hetzer; Arne Schäfer; Stefan Schreiber; Jian Chen; Isaac Neuhaus; Ruiru Ji; Nathan Siemers; Norbert Frey; Wolfgang Rottbauer; Hugo A Katus; Monika Stoll
HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy.
Genome research 2009;19(3):395-403.
2008: Norbert Frey; Derk Frank; Stefanie Lippl; Christian Kuhn; H Kögler; Tomasa Barrientos; Claudia Rohr; Rainer Will; Oliver J Müller; Hartmut Weiler; Rhonda Bassel-Duby; Hugo A Katus; Eric N Olson
Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation.
The Journal of clinical investigation 2008;118(11):3598-608.
2008: Mark Rosenberg; Christian Zugck; Manfred Nelles; Claus Juenger; Derk Frank; Andrew Remppis; Evangelos Giannitsis; Hugo A Katus; Norbert Frey
Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
Circulation. Heart failure 2008;1(1):43-9.
2008: Derk Frank; Christian Kuhn; Benedikt Brors; Christiane Hanselmann; Mark Lüdde; Hugo A Katus; Norbert Frey
Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program.
Hypertension 2008;51(2):309-18.
2008: Matthias Lutz; Mark Rosenberg; Fabian Kiessling; Volker Eckstein; Thomas Heger; Jutta Krebs; Anthony Ho; Hugo A Katus; Norbert Frey
Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.
Cardiovascular research 2008;77(1):143-50.
2007: Frank Schoensiegel; Raffi Bekeredjian; Anja Schrewe; Dieter Weichenhan; Norbert Frey; Hugo A Katus; Boris T Ivandic
Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice.
Comparative medicine 2007;57(6):546-53.
2007: Derk Frank; Christian Kuhn; Martin van Eickels; Doris Gehring; Christiane Hanselmann; Stefanie Lippl; Rainer Will; Hugo A Katus; Norbert Frey
Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Circulation 2007;116(22):2587-96.
2007: E Chorianopoulos; D Jäger; Hugo A Katus; Norbert Frey
Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib.
Clinical research in cardiology : official journal of the German Cardiac Society 2007;96(11):829-30.
2007: Hans-Joerg Hippe; Mark Luedde; Susanne Lutz; Henrike Koehler; Thomas Eschenhagen; Norbert Frey; Hugo A Katus; Thomas Wieland; Feraydoon Niroomand
Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes.
Circulation research 2007;100(8):1191-9.
2007: Erwin Blessing; Henning Steen; Mark Rosenberg; Hugo Katus; Norbert Frey
Recurrence of takotsubo cardiomyopathy with variant forms of left ventricular dysfunction.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2007;20(4):439.e11-2.
2007: Tomasa Barrientos; Derk Frank; Koichiro Kuwahara; Svetlana Bezprozvannaya; G C Teg Pipes; Rhonda Bassel-Duby; James A Richardson; Hugo A Katus; Eric N Olson; Norbert Frey
Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin.
The Journal of biological chemistry 2007;282(11):8393-403.
2007: Raffi Bekeredjian; F Joachim Meyer; Norbert Frey; Boris Radeleff
Massive tissue emphysema after cardiopulmonary resuscitation.
The American journal of emergency medicine 2007;25(1):101-2.
2006: Norbert Frey; Klara Brixius; Robert H G Schwinger; Thomas Benis; Alex Karpowski; Hans P Lorenzen; Mark Luedde; Hugo A Katus; Wolfgang M Franz
Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy.
The Journal of biological chemistry 2006;281(40):29575-82.
2006: Derk Frank; Christian Kuhn; Hugo A Katus; Norbert Frey
The sarcomeric Z-disc: a nodal point in signalling and disease.
Journal of molecular medicine (Berlin, Germany) 2006;84(6):446-68.
2006: M Rosenberg; H M Lorenz; N Gassler; Hugo A Katus; Norbert Frey
Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS).
Clinical research in cardiology : official journal of the German Cardiac Society 2006;95(5):289-94.
2006: Mark Luedde; Hugo A Katus; Norbert Frey
Novel molecular targets in the treatment of cardiac hypertrophy.
Recent patents on cardiovascular drug discovery 2006;1(1):1-20.
2004: Norbert Frey; Tomasa Barrientos; John M Shelton; Derk Frank; Hartmut Rütten; Doris Gehring; Christian Kuhn; Matthias Lutz; Beverly Rothermel; Rhonda Bassel-Duby; James A Richardson; Hugo A Katus; James A Hill; Eric N Olson
Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress.
Nature medicine 2004;10(12):1336-43.
2004: Norbert Frey; Hugo A Katus; Eric N Olson; Joseph A Hill
Hypertrophy of the heart: a new therapeutic target?
Circulation 2004;109(13):1580-9.
2003: Oliver J Müller; Mathias Lange; Henning Rattunde; Hans-Peter Lorenzen; Matthias Müller; Norbert Frey; Cordula Bittner; Warner S Simonides; Hugo A Katus; Wolfgang M Franz
Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload.
Cardiovascular research 2003;59(2):380-9.
2003: Norbert Frey; E N Olson
Cardiac hypertrophy: the good, the bad, and the ugly.
Annual review of physiology 2003;65():45-79.
2002: Volkhard Kurowski; Franz Hartmann; Dirk P Killermann; Evangelos Giannitsis; Uwe K H Wiegand; Norbert Frey; Margit Müller-Bardorff; Gert Richardt; Hugo A Katus
Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.
Critical care medicine 2002;30(10):2229-35.
2002: Norbert Frey; Eric N Olson
Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins.
The Journal of biological chemistry 2002;277(16):13998-4004.
2002: Christopher L Antos; Timothy A McKinsey; Norbert Frey; William Kutschke; John McAnally; John M Shelton; James A Richardson; James A Hill; Eric N Olson
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(2):907-12.
2001: Christopher L Antos; Norbert Frey; Steven O Marx; Steven Reiken; Marta Gaburjakova; James A Richardson; Andrew R Marks; Eric N Olson
Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.
Circulation research 2001;89(11):997-1004.
2001: Norbert Frey; A Dietz; Volkhard Kurowski; Evangelos Giannitsis; Ralph Tölg; Uwe K H Wiegand; Gert Richardt; Hugo A Katus
Angiographic correlates of a positive troponin T test in patients with unstable angina.
Critical care medicine 2001;29(6):1130-6.
2001: RL Nicol; Norbert Frey; G Pearson; Melanie Cobb; J Richardson; Eric N Olson
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.
The EMBO journal 2001;20(11):2757-67.
2000: Norbert Frey; James A Richardson; Eric N Olson
Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(26):14632-7.
2000: Jian Yang; Beverly Rothermel; Rick B Vega; Norbert Frey; Timothy A McKinsey; Eric N Olson; Rhonda Bassel-Duby; R Sanders Williams
Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.
Circulation research 2000;87(12):E61-8.
2000: Norbert Frey; Eric N Olson
Making matters worse for a broken heart.
The Journal of clinical investigation 2000;106(12):1437-9.
2000: Norbert Frey; Timothy A McKinsey; Eric N Olson
Decoding calcium signals involved in cardiac growth and function.
Nature medicine 2000;6(11):1221-7.
2000: Norbert Frey; Wolfgang M Franz; K Gloeckner; M Degenhardt; M Müller; O Müller; Hartmut Merz; Hugo A Katus
Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias.
Cardiovascular research 2000;47(2):254-64.
2000: Passier Robert; H Zeng; Norbert Frey; Francisco J Naya; RL Nicol; Timothy A McKinsey; P Overbeek; James A Richardson; S R Grant; Eric N Olson
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
The Journal of clinical investigation 2000;105(10):1395-406.
2000: RL Nicol; Norbert Frey; Eric N Olson
From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease.
Annual review of genomics and human genetics 2000;1():179-223.
1999: Franz Hartmann; Evangelos Giannitsis; Volkhard Kurowski; Norbert Frey; M Kampmann; Hugo A Katus
Risk stratification and therapeutic decision making in patients with acute coronary syndrome--the role of cardiac troponin T.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(11-12):1107-11.
1999: Wolfgang M Franz; O J Mueller; M Fleischmann; P Babij; Norbert Frey; M Mueller; Urban Besenfelder; A F Moorman; G Brem; Hugo A Katus
The 2.3 kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits.
Cardiovascular research 1999;43(4):1040-8.
1998: Franz Hartmann; M Kampmann; Norbert Frey; Margit Müller-Bardorff; Hugo A Katus
Biochemical markers in the diagnosis of coronary artery disease.
European heart journal 1998;19 Suppl N():N2-7.
1998: H A Katus; Norbert Frey; Margit Müller-Bardorff
Cardiac troponins in patients with chest pain.
The New England journal of medicine 1998;338(18):1314-5.
1998: Norbert Frey; Margit Müller-Bardorff; Hugo A Katus
[Value of laboratory parameters in risk assessment of patients with coronary heart disease and chronic myocardial ischemia].
Zeitschrift für Kardiologie 1998;87 Suppl 2():100-5.
1997: Wolfgang M Franz; T Rothmann; Norbert Frey; Hugo A Katus
Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters.
Cardiovascular research 1997;35(3):560-6.
1997: Wolfgang M Franz; O J Mueller; R Hartong; Norbert Frey; Hugo A Katus
Transgenic animal models: new avenues in cardiovascular physiology.
Journal of molecular medicine (Berlin, Germany) 1997;75(2):115-29.
1995: E Grünig; B Brown; Wolfgang M Franz; Joerg Zehelein; W Rottbauer; Norbert Frey; T Scheffold; Hugo A Katus
[Clinical aspects and follow-up in dilated cardiomyopathy].
Zeitschrift für Kardiologie 1995;84 Suppl 4():39-40.
1995: Wolfgang M Franz; Norbert Frey; O Müller; Wolfgang Kübler; Hugo A Katus
[A transgenic animal model: new possibilities for cardiovascular research].
Zeitschrift für Kardiologie 1995;84 Suppl 4():17-32.